• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MLO-Y4 骨细胞样细胞支持破骨细胞的形成和激活。

MLO-Y4 osteocyte-like cells support osteoclast formation and activation.

作者信息

Zhao S, Zhang Y Kato Y, Harris S, Ahuja S S, Bonewald L F

机构信息

Department of Medicine, University of Texas Health Science Center, San Antonio, USA.

出版信息

J Bone Miner Res. 2002 Nov;17(11):2068-79. doi: 10.1359/jbmr.2002.17.11.2068.

DOI:10.1359/jbmr.2002.17.11.2068
PMID:12412815
Abstract

Osteocytes are terminally differentiated cells of the osteoblast lineage that have become embedded in mineralized matrix and may send signals that regulate bone modeling and remodeling. The hypothesis to be tested in this study is that osteocytes can stimulate and support osteoclast formation and activation. To test this hypothesis, an osteocyte-like cell line called MLO-Y4 and primary murine osteocytes were used in coculture with spleen or marrow cells. MLO-Y4 cells support osteoclast formation in the absence of 1,25-dihydroxyvitamin D3 [1,25(OD)2D3] or any other exogenous osteotropic factor. These cells alone stimulate osteoclast formation to the same extent or greater than adding 1,25(OH)2D3. Coaddition of 1,25(OH)2D3 with MLO-Y4 cells synergistically increased osteoclast formation. Optimal osteoclast formation and pit formation on dentine was observed with 200-1,000 MLO-Y4 cells per 0.75-cm2 well. No osteoclast formation was observed with 2T3, OCT-1, or MC3T3-E1 osteoblast cells (1,000 cells/well). Conditioned media from the MLO-Y4 cells had no effect on osteoclast formation, indicating that cell contact is necessary. Serial digestions of 2-week-old mouse calvaria yielded populations of cells that support osteoclast formation when cocultured with 1,25(OH)2D3 and marrow, but the population that remained in the bone particles supported the greatest number of osteoclasts with or without 1,25(OH)2D3. To examine the mechanism whereby these cells support osteoclast formation, the MLO-Y4 cells were compared with a series of osteoblast and stromal cells for expression of macrophage colony-stimulating factor (M-CSF), RANKL, and osteoprotegerin (OPG). MLO-Y4 cells express and secrete large amounts of M-CSF. MLO-Y4 cells express RANKL on their surface and their dendritic processes. The ratio of RANKL to OPG mRNA is greatest in the MLO-Y4 cells compared with the other cell types. RANK-Fc and OPG-Fc blocked the formation of osteoclasts by MLO-Y4 cells. These studies suggest that both RANKL and OPG may play a role in osteocyte signaling, OPG and M-CSF as soluble factors and RANKL as a surface molecule that is functional in osteocytes or along their exposed dendritic processes.

摘要

骨细胞是成骨细胞谱系的终末分化细胞,已嵌入矿化基质中,并可能发出调节骨塑形和重塑的信号。本研究要检验的假设是骨细胞可以刺激并支持破骨细胞的形成和激活。为了验证这一假设,将一种名为MLO-Y4的类骨细胞系和原代小鼠骨细胞与脾细胞或骨髓细胞进行共培养。在没有1,25-二羟基维生素D3 [1,25(OH)2D3]或任何其他外源性促骨因子的情况下,MLO-Y4细胞支持破骨细胞的形成。这些细胞单独刺激破骨细胞形成的程度与添加1,25(OH)2D3相同或更大。1,25(OH)2D3与MLO-Y4细胞共同添加可协同增加破骨细胞的形成。每0.75平方厘米孔中接种200 - 1000个MLO-Y4细胞时,在牙本质上观察到最佳的破骨细胞形成和陷窝形成。2T3、OCT-1或MC3T3-E1成骨细胞(1000个细胞/孔)未观察到破骨细胞形成。MLO-Y4细胞的条件培养基对破骨细胞形成没有影响,表明细胞接触是必要的。对2周龄小鼠颅骨进行连续消化,得到的细胞群体与1,25(OH)2D3和骨髓共培养时支持破骨细胞形成,但留在骨颗粒中的细胞群体无论有无1,25(OH)2D3都支持最多数量的破骨细胞。为了研究这些细胞支持破骨细胞形成的机制,将MLO-Y4细胞与一系列成骨细胞和基质细胞比较巨噬细胞集落刺激因子(M-CSF)、核因子κB受体活化因子配体(RANKL)和骨保护素(OPG)的表达。MLO-Y4细胞表达并分泌大量的M-CSF。MLO-Y4细胞在其表面及其树突状突起上表达RANKL。与其他细胞类型相比,MLO-Y4细胞中RANKL与OPG mRNA的比例最大。RANK-Fc和OPG-Fc可阻断MLO-Y4细胞形成破骨细胞。这些研究表明RANKL和OPG可能在骨细胞信号传导中起作用,OPG和M-CSF作为可溶性因子,RANKL作为在骨细胞中或沿其暴露的树突状突起起作用的表面分子。

相似文献

1
MLO-Y4 osteocyte-like cells support osteoclast formation and activation.MLO-Y4 骨细胞样细胞支持破骨细胞的形成和激活。
J Bone Miner Res. 2002 Nov;17(11):2068-79. doi: 10.1359/jbmr.2002.17.11.2068.
2
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.成纤维细胞样基质细胞表达核因子κB受体活化因子配体并支持破骨细胞分化。
J Bone Miner Res. 2000 Aug;15(8):1459-66. doi: 10.1359/jbmr.2000.15.8.1459.
3
Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.表达重组甲状旁腺激素/甲状旁腺激素相关蛋白受体的SaOS-4/3细胞支持的破骨细胞生成中膜相关或基质相关形式的巨噬细胞集落刺激因子和核因子κB受体活化因子配体/骨保护素的重要性。
J Bone Miner Res. 2000 Sep;15(9):1766-75. doi: 10.1359/jbmr.2000.15.9.1766.
4
Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.微粗糙的种植体表面形貌通过减少破骨细胞的形成和活性来增加成骨作用。
J Biomed Mater Res A. 2004 Sep 1;70(3):361-9. doi: 10.1002/jbm.a.30025.
5
Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.人小梁骨来源的成骨细胞在特定的无血清培养基中可在体外支持人破骨细胞的形成。
J Cell Physiol. 2005 Jun;203(3):573-82. doi: 10.1002/jcp.20255.
6
Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.乳腺癌通过分泌巨噬细胞集落刺激因子(M-CSF)并上调基质细胞中的核因子κB受体活化因子配体(RANKL)来增加破骨细胞生成。
J Surg Res. 2001 Sep;100(1):18-24. doi: 10.1006/jsre.2001.6204.
7
Bone marrow cell differentiation induced by mechanically damaged osteocytes in 3D gel-embedded culture.三维凝胶包埋培养中机械损伤的骨细胞诱导骨髓细胞分化
J Bone Miner Res. 2006 Apr;21(4):616-25. doi: 10.1359/jbmr.060106. Epub 2006 Apr 5.
8
Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures.他汀类药物可调节小鼠骨细胞培养物中骨保护素/NFκB受体激活蛋白配体mRNA的水平。
Horm Metab Res. 2005 Oct;37(10):589-92. doi: 10.1055/s-2005-870538.
9
Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.环磷酸腺苷/蛋白激酶A介导甲状旁腺激素/甲状旁腺激素相关蛋白受体对破骨细胞生成以及骨髓基质细胞中核因子κB受体活化因子配体(RANKL)和骨保护素mRNA表达的调控。
J Bone Miner Res. 2002 Sep;17(9):1667-79. doi: 10.1359/jbmr.2002.17.9.1667.
10
Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.骨基质中的骨钙素片段在破骨细胞分化后期增强破骨细胞成熟。
J Bone Miner Metab. 2004;22(5):415-29. doi: 10.1007/s00774-004-0503-5.

引用本文的文献

1
Angiotensin II Promotes Osteocyte RANKL Expression via AT1R Activation.血管紧张素II通过激活AT1R促进骨细胞RANKL表达。
Biomedicines. 2025 Feb 10;13(2):426. doi: 10.3390/biomedicines13020426.
2
Water Extract of Nakai Inhibits Osteoclast Differentiation and Alleviates Ovariectomy-Induced Bone Loss.中田水提取物抑制破骨细胞分化并缓解卵巢切除诱导的骨丢失。
Int J Mol Sci. 2024 Oct 29;25(21):11616. doi: 10.3390/ijms252111616.
3
Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective.弥合对骨转移认识的差距:多维度视角
Int J Mol Sci. 2024 Feb 29;25(5):2846. doi: 10.3390/ijms25052846.
4
3D bioprinting technology to construct bone reconstruction research model and its feasibility evaluation.用于构建骨重建研究模型的3D生物打印技术及其可行性评估。
Front Bioeng Biotechnol. 2024 Jan 19;12:1328078. doi: 10.3389/fbioe.2024.1328078. eCollection 2024.
5
Ferroptosis in Osteocytes as a Target for Protection Against Postmenopausal Osteoporosis.成骨细胞铁死亡作为防治绝经后骨质疏松症的靶点
Adv Sci (Weinh). 2024 Mar;11(12):e2307388. doi: 10.1002/advs.202307388. Epub 2024 Jan 17.
6
Fluoxetine treatment during the postpartal period may have short-term impacts on murine maternal skeletal physiology.产后期间使用氟西汀治疗可能会对小鼠母体骨骼生理产生短期影响。
Front Pharmacol. 2023 Nov 23;14:1244580. doi: 10.3389/fphar.2023.1244580. eCollection 2023.
7
Ethanol Extract of Radix Asteris Suppresses Osteoclast Differentiation and Alleviates Osteoporosis.茵陈乙醇提取物抑制破骨细胞分化并缓解骨质疏松症。
Int J Mol Sci. 2023 Nov 20;24(22):16526. doi: 10.3390/ijms242216526.
8
Anti-Osteoporotic Potential of Water Extract of L. Seeds.莱菔子水提物的抗骨质疏松作用
Nutrients. 2023 Oct 9;15(19):4302. doi: 10.3390/nu15194302.
9
Water Extract of Inhibits Osteoclast Differentiation and Bone Loss.水提物抑制破骨细胞分化和骨丢失。
Int J Mol Sci. 2023 Sep 28;24(19):14715. doi: 10.3390/ijms241914715.
10
Denosumab treatment and infection risks in patients with osteoporosis: propensity score matching analysis of a national-wide population-based cohort study.地舒单抗治疗骨质疏松症患者与感染风险:一项全国范围内基于人群队列研究的倾向评分匹配分析。
Front Endocrinol (Lausanne). 2023 May 19;14:1182753. doi: 10.3389/fendo.2023.1182753. eCollection 2023.